Filter by:

A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch®® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps

Cancers |
View Article

Cancer

3D Genomics

Evaluation of EpiSwitch in predicting immunotherapy response in hepatocellular carcinoma and gastrointestinal tumors

Journal of Clinical Oncology |
View Article

Cancer

3D Genomics

A New Blood-Based Epigenetic Diagnostic Biomarker Test (Episwitch® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps

Preprints |
View Article

Cancer

3D Genomics

Development and evaluation of blood-based prognostic biomarkers for COVID disease outcomes using EpiSwitch 3-dimensional genomic regulatory immuno-genetic profiling

The European Society of Medicine |
View Article

Infectious disease

Autoimmune

3D Genomics

Whole Genome 3D Blood Biopsy Profiling of Canine Cancers: Development and Validation of EpiSwitch Multi-Choice Array-Based Diagnostic Test

BioRxiv |
View Article

Cancer

3D Genomics

Canine

Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications

Cancers |
View Article

Cancer